Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01182558 · ClinicalTrials.gov registry record · NA
The Effect of Prior Muscle Activation on the Compound Muscle Action Potential (CMAP)
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01182558 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 6 participants.
The verdict
NCT01182558, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this investigator-initiated study is to determine the effect of prior muscle activation on the response obtained by nerve conduction studies (the compound muscle action potential \[CMAP\]) looking at the amplitude, area, and duration of the CMAP and evaluating the length of time the CMAP is larger than at baseline. On the opposite side, the corresponding CMAP will be tested periodically, but there will be no muscle activation on that side. Null Hypothesis: While controlling all possible technical and other known physiological variables, prior activation of a muscle has no effect on the amplitude and area of the compound muscle action potential (CMAP); and the CMAP does not change over time in the relaxed muscle (on the opposite side). The investigators suspect that there is an effect of prior activation of the muscle on the subsequent CMAP recorded from that muscle.
Interventions
- OTHER Hypothenar muscle activation--maximum, voluntary, isometric
- OTHER Thenar muscle activation--maximum, voluntary, isometric
- OTHER EDB muscle activation--maximum, voluntary, isometric
- OTHER Relaxation of muscle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2010-10 |
| Est. Completion | 2019-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01182558
The ClinicalTrials.gov registry entry for NCT01182558 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Hypothenar muscle activation--maximum, voluntary, isometric is the first listed.
NCT01182558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01182558 about?
NCT01182558 is a clinical study titled "The Effect of Prior Muscle Activation on the Compound Muscle Action Potential (CMAP)". The purpose of this investigator-initiated study is to determine the effect of prior muscle activation on the response obtained by nerve conduction studies (the compound muscle action potential \[CMAP\]) looking at the amplitude, area, and duration of the CMAP and evaluating the length of time the C...
What is the current status of trial NCT01182558?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2010-10. Estimated completion is 2019-08.
What interventions are being tested in trial NCT01182558?
The interventions under investigation include: Hypothenar muscle activation--maximum, voluntary, isometric (OTHER), Thenar muscle activation--maximum, voluntary, isometric (OTHER), EDB muscle activation--maximum, voluntary, isometric (OTHER), Relaxation of muscle (OTHER).
Who is sponsoring clinical trial NCT01182558?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.